
BIOE does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for BIOE and 80,000+ other tickers.
See exactly how BIOE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BIOE and 80,000+ other tickers.
Bio Essence Corporation is a global enterprise specializing in herbal health, dietary, and nutritional solutions. It supplies healthcare professionals with a diverse range of herbal remedies, offered in various forms such as granules, capsules, pills, and tablets. Furthermore, the company extends custom formulation and original equipment manufacturing (OEM) services to these practitioners and manufactures and distributes its own line of health supplements. Founded in 2000, Bio Essence Corporation maintains its corporate headquarters in Irvine, California.

Global AI in Fitness and Wellness Market Size was valued at USD 10.68 Billion in 2025 and is predicted to reach USD 57.80 Billion by the year 2035 at a 19.3% CAGR during the forecast period for 2026 to 2035. IRVINE, CA / ACCESS Newswire / April 27, 2026 / Bio Essence Corporation (OTCQB:BIOE) ("Bio Essence" or the "Company"), a specialized health and wellness provider, today announced that it has entered into a definitive Asset Purchase Agreement to acquire the MediFlow AI platform from Zhituo Software Co., Limited.

The company's approval to upgrade to the OTCQB Venture Market underscores a growing trend among international, growth-stage companies to expand U.S. investor access and enhance market liquidity. The OTCQB® Venture Market is designed for entrepreneurial and development-stage companies in the United States and abroad.